title: Use of botulinum toxin type A in management of adult spasticity--a European consensus statement.
authors.affiliation: Department of Rehabilitation Medicine, North Staffordshire Hospital, Stoke-on Trent, UK.
authors.forename: Anthony B
authors.initials: AB
authors.lastname: Ward
authors.forename: Miguel
authors.initials: M
authors.lastname: Aguilar
authors.forename: Zegers
authors.initials: Z
authors.lastname: De Beyl
authors.forename: Susanne
authors.initials: S
authors.lastname: Gedin
authors.forename: Petr
authors.initials: P
authors.lastname: Kanovsky
authors.forename: Franco
authors.initials: F
authors.lastname: Molteni
authors.forename: Jörg
authors.initials: J
authors.lastname: Wissel
authors.forename: Anton
authors.initials: A
authors.lastname: Yakovleff
mesh_terms: D000328:Adult; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000627:therapeutic use*; D032921:Consensus; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005060:Europe; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D009128:Muscle Spasticity / Q000175:diagnosis / Q000188:drug therapy* / Q000534:rehabilitation; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D019274:Botulinum Toxins, Type A